ScirosBio

ScirosBio is a biopharmaceutical platform start-up engaged in the research, development, and commercialization of drugs for various disease indications — including oncology, neurological disorders, and diabetes. The company's RAID technology platform utilizes a combination of ROS modulating small molecules synergistically with other standard therapeutics to enhance the therapy outcome. It provides well-understood active substances with a high safety profile for rapid clinical development.